Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells

  • Authors:
    • Igor Bryukhovetskiy
    • Valeriy Shevchenko
  • View Affiliations

  • Published online on: June 22, 2016     https://doi.org/10.3892/ol.2016.4756
  • Pages: 1581-1590
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioblastoma multiforme (GBM) is the most widespread and aggressive type of primary brain tumor. The prognosis following diagnosis with GBM is poor, with a median survival time of 14 months. Tumor cell invasion, metastasis and proliferation are the major causes of mortality in patients with GBM. In order to develop effective GBM treatment methods it is necessary to identify novel targets involved in these processes. Recently, there has been increasing interest in investigating the signaling pathways involved in GBM development, and the transforming growth factor‑β (TGF‑β) signaling pathway is understood to be significant for regulating the behavior of GBM, as well as stimulating its invasion and metastatic development. Particular interest has been given to investigating the modulation of TGF‑β‑induced epithelial‑to‑mesenchymal transition (EMT); during this process, epithelial cells transdifferentiate into mobile cells with a mesenchymal phenotype. The induction of EMT increases the invasiveness of various types of carcinoma; however, the role of TGF‑β in this process remains to be elucidated, particularly in the case of GBM. The current study presents a comparative proteome mapping of the U87 human glioblastoma cell line, with and without TGF-β1 treatment. Proteome analysis identified numerous proteins involved in the molecular mechanisms of GBM oncogenesis and TGF-β1 signaling in glioblastoma. The results of the present study facilitated the identification of novel potential markers of metastasis and candidates for targeted glioblastoma therapy, which may potentially be validated and used in clinical medicine to develop improved approaches for GBM diagnosis and treatment.
View References

Related Articles

Journal Cover

August-2016
Volume 12 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bryukhovetskiy I and Shevchenko V: Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells. Oncol Lett 12: 1581-1590, 2016.
APA
Bryukhovetskiy, I., & Shevchenko, V. (2016). Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells. Oncology Letters, 12, 1581-1590. https://doi.org/10.3892/ol.2016.4756
MLA
Bryukhovetskiy, I., Shevchenko, V."Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells". Oncology Letters 12.2 (2016): 1581-1590.
Chicago
Bryukhovetskiy, I., Shevchenko, V."Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells". Oncology Letters 12, no. 2 (2016): 1581-1590. https://doi.org/10.3892/ol.2016.4756